Latest Breaking News On - Medicare administrative carrier - Page 1 : vimarsana.com

Aspira Women s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

Aspira Women s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesNicole sandfordTorsten hombeckJamie sullivandirector of corporate communicationsaspira women healthHc wainwright coInc aspira women healthAspira women health incBeacon grand hotelSir francis drake hotelExchange commissionDrug administrationWomen health incHealthcare conference weekChief executive officerChief financial officer

Aspira Women s Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS) -November 27, 2023 at 09:48 am EST

CMS approves OvaWatchSM 2024 price at $897 per test AUSTIN, Texas, Nov. 27, 2023 Aspira Women’s Health Inc. , a bio-analytical company focused on the development and commercialization of.

United statesNew yorkNicole sandfordJamie sullivanCenters for medicare medicaid servicesGlobenewswire incAspira women healthClinical laboratory fee scheduleDrug administrationHealth incAspira women health incCorporate communicationsLaboratory fee scheduleMedicaid servicesChief executive officerPrivate securities litigation reform act

Aspira Women s Health Reports Third Quarter 2023 Financial Results

Product revenue increased 9% to $2.2 million for the quarter, and 19% to $7.0 million year to dateOvaSuite sales volume increased 5% to 5,783 unit.

United statesMonique kosseNicole sandfordNisha gargTamika seaLeo twiggsJody berryKevin eliasAspira women health incDrug administrationWomen care centerAmerican association of cancer researchUniversity of lodzDana farber cancer instituteAspira women health investor relationsElias laboratory

Aspira Women s Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch

The proposed rule would allow for OvaWatchSM to be reimbursed at the same rate as Ova1® at $897 per test and will become final following a brief public comment period AUSTIN, Texas, Nov. 09, 2023 (GLOBE NEWSWIRE) Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, today announced that during the 2024 Clinical Laboratory Fee Schedule (CLFS) ra

United statesNew yorkMonique kosseNicole sandfordLifesci advisorsDrug administrationClinical laboratory fee scheduleAspira women health incWomen health incCenters for medicare medicaid servicesLaboratory fee scheduleMedicaid servicesChief executive officerPrivate securities litigation reform actAnnual reportMedicare administrative carrier

Aspira Women s Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research -October 25, 2023 at 08:01 am EDT

AUSTIN, Texas, Oct. 25, 2023 Aspira Women’s Health Inc. , a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic.

United statesNew yorkDana farber cancer instituteNicole sandfordMonique kosseKevin eliasProviders of the aspira women healthAspira women healthLifesci advisorsAspira women health incCompany ovasuiteGlobenewswire incGynecologic oncology laboratory at brighamDrug administrationHealth incCancer research